Form 4/A for CNO CNO Financial Group, Inc.
Accepted 2026-02-12 00:00:00 ET · period of report 2023-02-10 · accession 0001740471-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2026-02-12 | 2023-02-10 | CNO | Goldberg Scott L. | Pres, Consumer Division | M - OptEx | $16.42 | +17.1K | 154.4K | +12% | +$280.7K |
| DA | 2026-02-12 | 2023-02-10 | CNO | Goldberg Scott L. | Pres, Consumer Division | S - Sale+OE | $25.34 | -17.1K | 137.3K | -11% | -$433.2K |
| DA | 2026-02-12 | 2023-02-10 | CNO | Goldberg Scott L. | Pres, Consumer Division | M - OptEx | $0.00 | -17.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-10 | M | A | 17,095 | $16.42 | 154,400 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-10 | S | D | 17,095 | $25.34 | 137,305 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 trading plan adopted on November 11, 2022. (F2) Reflects the weighted average sale price. Shares were sold at prices ranging from $25.15 per share to $25.50 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. (F3) This amendment corrects (i) the presentation of the exercise of stock options and (ii) the amount of securities beneficially owned following the transactions reported on this Form 4/A. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2023-02-10 | M | D | 17,095 | $0.00 | 0 | D | $16.42 · — to — | 17,095 Common Stock | (F4) The stock options vested and became exercisable on February 25, 2018. (F5) The expiration date was February 25, 2025. |